Premium
RADIOMICS INCREASE THE PROGNOSTIC VALUE OF CLINICAL AND PET RISK FACTORS IN DLBCL: RESULTS FROM THE PHASE 3 GOYA STUDY
Author(s) -
Chauvie S.,
Dalmasso F.,
Pierce L.,
Vitolo U.,
Martelli M.,
Sehn L.H.,
Trněný M.,
Nielsen T.,
Sahin D.,
Lee C.,
Mattiello F.,
Berchialla P.,
Kinahan P.E.,
Kostakoglu L.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.21_2629
Subject(s) - medicine , proportional hazards model , oncology , radiomics , vincristine , nuclear medicine , imaging biomarker , radiology , chemotherapy , magnetic resonance imaging , cyclophosphamide
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom